J CANCER RES CLIN 润色咨询

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

出版年份:1979 年文章数:3146 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2191590, encodeId=dce6219159003, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:还是比较快的<br>Submission is in publishing and rights<br>05 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>05 Mar 2024<br>Submission under peer review<br>16 Feb 2024<br>Submission passed technical check<br>16 Feb 2024<br>Revision received<br>15 Feb 2024<br>Submission under peer review<br>11 Jan 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>11 Jan 2024<br>Submission is under technical check<br>10 Jan 2024<br>Submission received<br>Submission status Date<br>Submission received<br>10 Jan 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e8382356, createdName=ms5000001486959246, createdTime=Wed Mar 06 21:41:34 CST 2024, time=2024-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=124, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195480, encodeId=7e252195480ef, content=求问各位已经proof的大神,接收后一般多久能proof呀?accept是3.11,到现在都没有消息,有些紧张……提前感谢各位大神的解答!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e08675679, createdName=ms6000000287967542, createdTime=Tue Mar 26 18:56:08 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向:肿瘤<br>经验分享:记录:生信加验证 23.12.12投稿 24.1.17返两个审稿人意见,都是小修,加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2191574, encodeId=675421915e4a7, content=偏重的研究方向:肿瘤基础研究<br>经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:45:16 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2194218, encodeId=432a2194218a4, content=偏重的研究方向:临床肿瘤基础研究<br>经验分享:有没有知道的大佬们,临床肿瘤基础研究这个杂志收不收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230522/2d526ad49c9d4a238ea5253f6b93381d/a6944e09a4254363923c04ea9167b795.jpg, createdBy=e0d95253850, createdName=lmzzzh, createdTime=Wed Mar 20 09:43:23 CST 2024, time=2024-03-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2191575, encodeId=455e21915e55e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;基础研究<br>经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:47:39 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192970, encodeId=095d21929e092, content=偏重的研究方向:肿瘤临床;肿瘤<br>经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=613c5613981, createdName=ms9000000002911795, createdTime=Wed Mar 13 15:01:47 CST 2024, time=2024-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2185219, encodeId=922b218521981, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Feb 01 14:16:21 CST 2024, time=2024-02-01, status=1, ipAttribution=北京)]
    2024-03-06 ms5000001486959246 来自北京

    审稿速度:2.0 | 投稿命中率:75.0
    偏重的研究方向:肿瘤
    经验分享:还是比较快的
    Submission is in publishing and rights
    05 Mar 2024
    Peer review
    Submission status Date
    Submission accepted
    05 Mar 2024
    Submission under peer review
    16 Feb 2024
    Submission passed technical check
    16 Feb 2024
    Revision received
    15 Feb 2024
    Submission under peer review
    11 Jan 2024
    Technical check
    Submission status Date
    Submission passed technical check
    11 Jan 2024
    Submission is under technical check
    10 Jan 2024
    Submission received
    Submission status Date
    Submission received
    10 Jan 2024

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2191590, encodeId=dce6219159003, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:还是比较快的<br>Submission is in publishing and rights<br>05 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>05 Mar 2024<br>Submission under peer review<br>16 Feb 2024<br>Submission passed technical check<br>16 Feb 2024<br>Revision received<br>15 Feb 2024<br>Submission under peer review<br>11 Jan 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>11 Jan 2024<br>Submission is under technical check<br>10 Jan 2024<br>Submission received<br>Submission status Date<br>Submission received<br>10 Jan 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e8382356, createdName=ms5000001486959246, createdTime=Wed Mar 06 21:41:34 CST 2024, time=2024-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=124, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195480, encodeId=7e252195480ef, content=求问各位已经proof的大神,接收后一般多久能proof呀?accept是3.11,到现在都没有消息,有些紧张……提前感谢各位大神的解答!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e08675679, createdName=ms6000000287967542, createdTime=Tue Mar 26 18:56:08 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向:肿瘤<br>经验分享:记录:生信加验证 23.12.12投稿 24.1.17返两个审稿人意见,都是小修,加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2191574, encodeId=675421915e4a7, content=偏重的研究方向:肿瘤基础研究<br>经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:45:16 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2194218, encodeId=432a2194218a4, content=偏重的研究方向:临床肿瘤基础研究<br>经验分享:有没有知道的大佬们,临床肿瘤基础研究这个杂志收不收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230522/2d526ad49c9d4a238ea5253f6b93381d/a6944e09a4254363923c04ea9167b795.jpg, createdBy=e0d95253850, createdName=lmzzzh, createdTime=Wed Mar 20 09:43:23 CST 2024, time=2024-03-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2191575, encodeId=455e21915e55e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;基础研究<br>经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:47:39 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192970, encodeId=095d21929e092, content=偏重的研究方向:肿瘤临床;肿瘤<br>经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=613c5613981, createdName=ms9000000002911795, createdTime=Wed Mar 13 15:01:47 CST 2024, time=2024-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2185219, encodeId=922b218521981, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Feb 01 14:16:21 CST 2024, time=2024-02-01, status=1, ipAttribution=北京)]
    2020-06-12 ms5502585941462392

    9月28投稿,10月7日直接接收,还以为是拒稿。😀

    124

    展开124条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2191590, encodeId=dce6219159003, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:还是比较快的<br>Submission is in publishing and rights<br>05 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>05 Mar 2024<br>Submission under peer review<br>16 Feb 2024<br>Submission passed technical check<br>16 Feb 2024<br>Revision received<br>15 Feb 2024<br>Submission under peer review<br>11 Jan 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>11 Jan 2024<br>Submission is under technical check<br>10 Jan 2024<br>Submission received<br>Submission status Date<br>Submission received<br>10 Jan 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e8382356, createdName=ms5000001486959246, createdTime=Wed Mar 06 21:41:34 CST 2024, time=2024-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=124, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195480, encodeId=7e252195480ef, content=求问各位已经proof的大神,接收后一般多久能proof呀?accept是3.11,到现在都没有消息,有些紧张……提前感谢各位大神的解答!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e08675679, createdName=ms6000000287967542, createdTime=Tue Mar 26 18:56:08 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向:肿瘤<br>经验分享:记录:生信加验证 23.12.12投稿 24.1.17返两个审稿人意见,都是小修,加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2191574, encodeId=675421915e4a7, content=偏重的研究方向:肿瘤基础研究<br>经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:45:16 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2194218, encodeId=432a2194218a4, content=偏重的研究方向:临床肿瘤基础研究<br>经验分享:有没有知道的大佬们,临床肿瘤基础研究这个杂志收不收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230522/2d526ad49c9d4a238ea5253f6b93381d/a6944e09a4254363923c04ea9167b795.jpg, createdBy=e0d95253850, createdName=lmzzzh, createdTime=Wed Mar 20 09:43:23 CST 2024, time=2024-03-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2191575, encodeId=455e21915e55e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;基础研究<br>经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:47:39 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192970, encodeId=095d21929e092, content=偏重的研究方向:肿瘤临床;肿瘤<br>经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=613c5613981, createdName=ms9000000002911795, createdTime=Wed Mar 13 15:01:47 CST 2024, time=2024-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2185219, encodeId=922b218521981, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Feb 01 14:16:21 CST 2024, time=2024-02-01, status=1, ipAttribution=北京)]
    2024-03-26 ms6000000287967542 来自浙江省

    求问各位已经proof的大神,接收后一般多久能proof呀?accept是3.11,到现在都没有消息,有些紧张……提前感谢各位大神的解答!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2191590, encodeId=dce6219159003, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:还是比较快的<br>Submission is in publishing and rights<br>05 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>05 Mar 2024<br>Submission under peer review<br>16 Feb 2024<br>Submission passed technical check<br>16 Feb 2024<br>Revision received<br>15 Feb 2024<br>Submission under peer review<br>11 Jan 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>11 Jan 2024<br>Submission is under technical check<br>10 Jan 2024<br>Submission received<br>Submission status Date<br>Submission received<br>10 Jan 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e8382356, createdName=ms5000001486959246, createdTime=Wed Mar 06 21:41:34 CST 2024, time=2024-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=124, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195480, encodeId=7e252195480ef, content=求问各位已经proof的大神,接收后一般多久能proof呀?accept是3.11,到现在都没有消息,有些紧张……提前感谢各位大神的解答!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e08675679, createdName=ms6000000287967542, createdTime=Tue Mar 26 18:56:08 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向:肿瘤<br>经验分享:记录:生信加验证 23.12.12投稿 24.1.17返两个审稿人意见,都是小修,加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2191574, encodeId=675421915e4a7, content=偏重的研究方向:肿瘤基础研究<br>经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:45:16 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2194218, encodeId=432a2194218a4, content=偏重的研究方向:临床肿瘤基础研究<br>经验分享:有没有知道的大佬们,临床肿瘤基础研究这个杂志收不收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230522/2d526ad49c9d4a238ea5253f6b93381d/a6944e09a4254363923c04ea9167b795.jpg, createdBy=e0d95253850, createdName=lmzzzh, createdTime=Wed Mar 20 09:43:23 CST 2024, time=2024-03-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2191575, encodeId=455e21915e55e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;基础研究<br>经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:47:39 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192970, encodeId=095d21929e092, content=偏重的研究方向:肿瘤临床;肿瘤<br>经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=613c5613981, createdName=ms9000000002911795, createdTime=Wed Mar 13 15:01:47 CST 2024, time=2024-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2185219, encodeId=922b218521981, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Feb 01 14:16:21 CST 2024, time=2024-02-01, status=1, ipAttribution=北京)]
    2024-01-19 ms3000000321226977

    偏重的研究方向:肿瘤
    经验分享:记录:生信加验证 23.12.12投稿 24.1.17返两个审稿人意见,都是小修,加起来6条意见

    12

    展开12条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2191590, encodeId=dce6219159003, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:还是比较快的<br>Submission is in publishing and rights<br>05 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>05 Mar 2024<br>Submission under peer review<br>16 Feb 2024<br>Submission passed technical check<br>16 Feb 2024<br>Revision received<br>15 Feb 2024<br>Submission under peer review<br>11 Jan 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>11 Jan 2024<br>Submission is under technical check<br>10 Jan 2024<br>Submission received<br>Submission status Date<br>Submission received<br>10 Jan 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e8382356, createdName=ms5000001486959246, createdTime=Wed Mar 06 21:41:34 CST 2024, time=2024-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=124, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195480, encodeId=7e252195480ef, content=求问各位已经proof的大神,接收后一般多久能proof呀?accept是3.11,到现在都没有消息,有些紧张……提前感谢各位大神的解答!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e08675679, createdName=ms6000000287967542, createdTime=Tue Mar 26 18:56:08 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向:肿瘤<br>经验分享:记录:生信加验证 23.12.12投稿 24.1.17返两个审稿人意见,都是小修,加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2191574, encodeId=675421915e4a7, content=偏重的研究方向:肿瘤基础研究<br>经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:45:16 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2194218, encodeId=432a2194218a4, content=偏重的研究方向:临床肿瘤基础研究<br>经验分享:有没有知道的大佬们,临床肿瘤基础研究这个杂志收不收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230522/2d526ad49c9d4a238ea5253f6b93381d/a6944e09a4254363923c04ea9167b795.jpg, createdBy=e0d95253850, createdName=lmzzzh, createdTime=Wed Mar 20 09:43:23 CST 2024, time=2024-03-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2191575, encodeId=455e21915e55e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;基础研究<br>经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:47:39 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192970, encodeId=095d21929e092, content=偏重的研究方向:肿瘤临床;肿瘤<br>经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=613c5613981, createdName=ms9000000002911795, createdTime=Wed Mar 13 15:01:47 CST 2024, time=2024-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2185219, encodeId=922b218521981, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Feb 01 14:16:21 CST 2024, time=2024-02-01, status=1, ipAttribution=北京)]
    2024-03-12 ms6000001537745536 来自四川省

    二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed

    5

    展开5条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2191590, encodeId=dce6219159003, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:还是比较快的<br>Submission is in publishing and rights<br>05 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>05 Mar 2024<br>Submission under peer review<br>16 Feb 2024<br>Submission passed technical check<br>16 Feb 2024<br>Revision received<br>15 Feb 2024<br>Submission under peer review<br>11 Jan 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>11 Jan 2024<br>Submission is under technical check<br>10 Jan 2024<br>Submission received<br>Submission status Date<br>Submission received<br>10 Jan 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e8382356, createdName=ms5000001486959246, createdTime=Wed Mar 06 21:41:34 CST 2024, time=2024-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=124, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195480, encodeId=7e252195480ef, content=求问各位已经proof的大神,接收后一般多久能proof呀?accept是3.11,到现在都没有消息,有些紧张……提前感谢各位大神的解答!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e08675679, createdName=ms6000000287967542, createdTime=Tue Mar 26 18:56:08 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向:肿瘤<br>经验分享:记录:生信加验证 23.12.12投稿 24.1.17返两个审稿人意见,都是小修,加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2191574, encodeId=675421915e4a7, content=偏重的研究方向:肿瘤基础研究<br>经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:45:16 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2194218, encodeId=432a2194218a4, content=偏重的研究方向:临床肿瘤基础研究<br>经验分享:有没有知道的大佬们,临床肿瘤基础研究这个杂志收不收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230522/2d526ad49c9d4a238ea5253f6b93381d/a6944e09a4254363923c04ea9167b795.jpg, createdBy=e0d95253850, createdName=lmzzzh, createdTime=Wed Mar 20 09:43:23 CST 2024, time=2024-03-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2191575, encodeId=455e21915e55e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;基础研究<br>经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:47:39 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192970, encodeId=095d21929e092, content=偏重的研究方向:肿瘤临床;肿瘤<br>经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=613c5613981, createdName=ms9000000002911795, createdTime=Wed Mar 13 15:01:47 CST 2024, time=2024-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2185219, encodeId=922b218521981, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Feb 01 14:16:21 CST 2024, time=2024-02-01, status=1, ipAttribution=北京)]
    2024-03-06 ms8000000280791103 来自重庆

    偏重的研究方向:肿瘤基础研究
    经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2191590, encodeId=dce6219159003, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:还是比较快的<br>Submission is in publishing and rights<br>05 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>05 Mar 2024<br>Submission under peer review<br>16 Feb 2024<br>Submission passed technical check<br>16 Feb 2024<br>Revision received<br>15 Feb 2024<br>Submission under peer review<br>11 Jan 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>11 Jan 2024<br>Submission is under technical check<br>10 Jan 2024<br>Submission received<br>Submission status Date<br>Submission received<br>10 Jan 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e8382356, createdName=ms5000001486959246, createdTime=Wed Mar 06 21:41:34 CST 2024, time=2024-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=124, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195480, encodeId=7e252195480ef, content=求问各位已经proof的大神,接收后一般多久能proof呀?accept是3.11,到现在都没有消息,有些紧张……提前感谢各位大神的解答!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e08675679, createdName=ms6000000287967542, createdTime=Tue Mar 26 18:56:08 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向:肿瘤<br>经验分享:记录:生信加验证 23.12.12投稿 24.1.17返两个审稿人意见,都是小修,加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2191574, encodeId=675421915e4a7, content=偏重的研究方向:肿瘤基础研究<br>经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:45:16 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2194218, encodeId=432a2194218a4, content=偏重的研究方向:临床肿瘤基础研究<br>经验分享:有没有知道的大佬们,临床肿瘤基础研究这个杂志收不收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230522/2d526ad49c9d4a238ea5253f6b93381d/a6944e09a4254363923c04ea9167b795.jpg, createdBy=e0d95253850, createdName=lmzzzh, createdTime=Wed Mar 20 09:43:23 CST 2024, time=2024-03-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2191575, encodeId=455e21915e55e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;基础研究<br>经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:47:39 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192970, encodeId=095d21929e092, content=偏重的研究方向:肿瘤临床;肿瘤<br>经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=613c5613981, createdName=ms9000000002911795, createdTime=Wed Mar 13 15:01:47 CST 2024, time=2024-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2185219, encodeId=922b218521981, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Feb 01 14:16:21 CST 2024, time=2024-02-01, status=1, ipAttribution=北京)]
    2024-03-20 lmzzzh 来自河南省

    偏重的研究方向:临床肿瘤基础研究
    经验分享:有没有知道的大佬们,临床肿瘤基础研究这个杂志收不收

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2191590, encodeId=dce6219159003, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:还是比较快的<br>Submission is in publishing and rights<br>05 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>05 Mar 2024<br>Submission under peer review<br>16 Feb 2024<br>Submission passed technical check<br>16 Feb 2024<br>Revision received<br>15 Feb 2024<br>Submission under peer review<br>11 Jan 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>11 Jan 2024<br>Submission is under technical check<br>10 Jan 2024<br>Submission received<br>Submission status Date<br>Submission received<br>10 Jan 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e8382356, createdName=ms5000001486959246, createdTime=Wed Mar 06 21:41:34 CST 2024, time=2024-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=124, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195480, encodeId=7e252195480ef, content=求问各位已经proof的大神,接收后一般多久能proof呀?accept是3.11,到现在都没有消息,有些紧张……提前感谢各位大神的解答!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e08675679, createdName=ms6000000287967542, createdTime=Tue Mar 26 18:56:08 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向:肿瘤<br>经验分享:记录:生信加验证 23.12.12投稿 24.1.17返两个审稿人意见,都是小修,加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2191574, encodeId=675421915e4a7, content=偏重的研究方向:肿瘤基础研究<br>经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:45:16 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2194218, encodeId=432a2194218a4, content=偏重的研究方向:临床肿瘤基础研究<br>经验分享:有没有知道的大佬们,临床肿瘤基础研究这个杂志收不收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230522/2d526ad49c9d4a238ea5253f6b93381d/a6944e09a4254363923c04ea9167b795.jpg, createdBy=e0d95253850, createdName=lmzzzh, createdTime=Wed Mar 20 09:43:23 CST 2024, time=2024-03-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2191575, encodeId=455e21915e55e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;基础研究<br>经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:47:39 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192970, encodeId=095d21929e092, content=偏重的研究方向:肿瘤临床;肿瘤<br>经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=613c5613981, createdName=ms9000000002911795, createdTime=Wed Mar 13 15:01:47 CST 2024, time=2024-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2185219, encodeId=922b218521981, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Feb 01 14:16:21 CST 2024, time=2024-02-01, status=1, ipAttribution=北京)]
    2024-03-06 ms8000000280791103 来自重庆

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:肿瘤;基础研究
    经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊

    8

    展开8条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2191590, encodeId=dce6219159003, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:还是比较快的<br>Submission is in publishing and rights<br>05 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>05 Mar 2024<br>Submission under peer review<br>16 Feb 2024<br>Submission passed technical check<br>16 Feb 2024<br>Revision received<br>15 Feb 2024<br>Submission under peer review<br>11 Jan 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>11 Jan 2024<br>Submission is under technical check<br>10 Jan 2024<br>Submission received<br>Submission status Date<br>Submission received<br>10 Jan 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e8382356, createdName=ms5000001486959246, createdTime=Wed Mar 06 21:41:34 CST 2024, time=2024-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=124, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195480, encodeId=7e252195480ef, content=求问各位已经proof的大神,接收后一般多久能proof呀?accept是3.11,到现在都没有消息,有些紧张……提前感谢各位大神的解答!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e08675679, createdName=ms6000000287967542, createdTime=Tue Mar 26 18:56:08 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向:肿瘤<br>经验分享:记录:生信加验证 23.12.12投稿 24.1.17返两个审稿人意见,都是小修,加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2191574, encodeId=675421915e4a7, content=偏重的研究方向:肿瘤基础研究<br>经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:45:16 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2194218, encodeId=432a2194218a4, content=偏重的研究方向:临床肿瘤基础研究<br>经验分享:有没有知道的大佬们,临床肿瘤基础研究这个杂志收不收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230522/2d526ad49c9d4a238ea5253f6b93381d/a6944e09a4254363923c04ea9167b795.jpg, createdBy=e0d95253850, createdName=lmzzzh, createdTime=Wed Mar 20 09:43:23 CST 2024, time=2024-03-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2191575, encodeId=455e21915e55e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;基础研究<br>经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:47:39 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192970, encodeId=095d21929e092, content=偏重的研究方向:肿瘤临床;肿瘤<br>经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=613c5613981, createdName=ms9000000002911795, createdTime=Wed Mar 13 15:01:47 CST 2024, time=2024-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2185219, encodeId=922b218521981, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Feb 01 14:16:21 CST 2024, time=2024-02-01, status=1, ipAttribution=北京)]
    2024-03-13 ms9000000002911795 来自黑龙江省

    偏重的研究方向:肿瘤临床;肿瘤
    经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了

    3

    展开3条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2191590, encodeId=dce6219159003, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:还是比较快的<br>Submission is in publishing and rights<br>05 Mar 2024<br>Peer review<br>Submission status Date<br>Submission accepted<br>05 Mar 2024<br>Submission under peer review<br>16 Feb 2024<br>Submission passed technical check<br>16 Feb 2024<br>Revision received<br>15 Feb 2024<br>Submission under peer review<br>11 Jan 2024<br>Technical check<br>Submission status Date<br>Submission passed technical check<br>11 Jan 2024<br>Submission is under technical check<br>10 Jan 2024<br>Submission received<br>Submission status Date<br>Submission received<br>10 Jan 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad2e8382356, createdName=ms5000001486959246, createdTime=Wed Mar 06 21:41:34 CST 2024, time=2024-03-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=124, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195480, encodeId=7e252195480ef, content=求问各位已经proof的大神,接收后一般多久能proof呀?accept是3.11,到现在都没有消息,有些紧张……提前感谢各位大神的解答!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5e08675679, createdName=ms6000000287967542, createdTime=Tue Mar 26 18:56:08 CST 2024, time=2024-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2182701, encodeId=5bfd2182e01db, content=偏重的研究方向:肿瘤<br>经验分享:记录:生信加验证 23.12.12投稿 24.1.17返两个审稿人意见,都是小修,加起来6条意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cc7c5397146, createdName=ms3000000321226977, createdTime=Fri Jan 19 20:28:23 CST 2024, time=2024-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2192743, encodeId=01e12192e4309, content=二战这个杂志,去年5月投了篇临床预测模型seer数据库文章,大修后拒稿。这次又投了篇机器学习。不过感觉审稿速度慢了好多 3 Mar initial technical check 4 Mar technical check passed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=ms6000001537745536, createdTime=Tue Mar 12 13:06:33 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2191574, encodeId=675421915e4a7, content=偏重的研究方向:肿瘤基础研究<br>经验分享:难受啊,2月13提交的,然后一直都是有一个人接受审稿,直到2月29号,系统出现问题,就没有更新了。然后今天3月6号发了个邮件给编辑询问进度,然后系统就变成了这样:The editors' decision can take several weeks as they may consult peer reviewers. 还没有修过,是不是要被拒了啊。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:45:16 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2194218, encodeId=432a2194218a4, content=偏重的研究方向:临床肿瘤基础研究<br>经验分享:有没有知道的大佬们,临床肿瘤基础研究这个杂志收不收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230522/2d526ad49c9d4a238ea5253f6b93381d/a6944e09a4254363923c04ea9167b795.jpg, createdBy=e0d95253850, createdName=lmzzzh, createdTime=Wed Mar 20 09:43:23 CST 2024, time=2024-03-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2191575, encodeId=455e21915e55e, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;基础研究<br>经验分享:家人们,还没有修过变成这样了,The editors' decision can take several weeks as they may consult peer reviewers.是不是凉了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=733b8201136, createdName=ms8000000280791103, createdTime=Wed Mar 06 19:47:39 CST 2024, time=2024-03-06, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2192970, encodeId=095d21929e092, content=偏重的研究方向:肿瘤临床;肿瘤<br>经验分享:大神们,The eidtors' decision can take several weeks as they may consult peer reviews.这种状态是审了还是没审啊,2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=613c5613981, createdName=ms9000000002911795, createdTime=Wed Mar 13 15:01:47 CST 2024, time=2024-03-13, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2185219, encodeId=922b218521981, content=审稿速度:1.0<br>偏重的研究方向:肿瘤<br>经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c389144074, createdName=ms6000001259041667, createdTime=Thu Feb 01 14:16:21 CST 2024, time=2024-02-01, status=1, ipAttribution=北京)]
    2024-02-01 ms6000001259041667 来自北京

    审稿速度:1.0
    偏重的研究方向:肿瘤
    经验分享:邀请20个审稿人 15天拒稿 没理由 也不知道审没审啊

    2

    展开2条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分